ZS Pharma Stock Price, News & Analysis (NASDAQ:ZSPH)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About ZS Pharma (NASDAQ:ZSPH)

ZS Pharma logoZS Pharma, Inc. is a biopharmaceutical company focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. The Company's zirconium silicate technology allows it to create selective ion traps that can reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. The Company has completed Phase III development of its product candidate, sodium zirconium cyclosilicate (ZS-9), for the treatment of hyperkalemia, a life-threatening condition in which elevated levels of potassium increase the risk of muscle dysfunction, including cardiac arrhythmias and sudden cardiac death. The Company has completed three clinical studies with ZS-9 for patients with hyperkalemia, including patients with chronic kidney disease (CKD), heart failure (HF), diabetes and those on renin-angiotensin aldosterone system (RAAS) inhibitor therapy.

Receive ZSPH News and Ratings via Email

Sign-up to receive the latest news and ratings for ZSPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($4.72)
Net IncomeN/A
Net MarginsN/A
Return on Equity-66.24%
Return on Assets-58.88%


Outstanding SharesN/A

ZS Pharma (NASDAQ:ZSPH) Frequently Asked Questions

What is ZS Pharma's stock symbol?

ZS Pharma trades on the NASDAQ under the ticker symbol "ZSPH."

How were ZS Pharma's earnings last quarter?

ZS Pharma Inc (NASDAQ:ZSPH) released its quarterly earnings results on Monday, November, 9th. The biopharmaceutical company reported ($0.41) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($1.04) by $0.63. View ZS Pharma's Earnings History.

Who are some of ZS Pharma's key competitors?

How do I buy ZS Pharma stock?

Shares of ZS Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact ZS Pharma?

ZS Pharma's mailing address is 508 Wrangler Dr Ste 100, COPPELL, TX 75019-7609, United States. The biopharmaceutical company can be reached via phone at +1-650-4584100.

MarketBeat Community Rating for ZS Pharma (ZSPH)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about ZS Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ZS Pharma (NASDAQ:ZSPH) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


ZS Pharma (NASDAQ:ZSPH) Earnings History and Estimates Chart

Earnings by Quarter for ZS Pharma (NASDAQ:ZSPH)

ZS Pharma (NASDAQ ZSPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2015Q315($1.04)($0.41)ViewN/AView Earnings Details
8/6/2015($0.90)($1.30)ViewN/AView Earnings Details
5/11/2015Q115($0.86)($1.05)ViewN/AView Earnings Details
3/13/2015Q414($0.75)($0.98)ViewN/AView Earnings Details
11/10/2014Q314($0.74)($0.81)ViewN/AView Earnings Details
8/14/2014Q214($0.66)($4.72)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


ZS Pharma (NASDAQ:ZSPH) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for ZS Pharma (NASDAQ:ZSPH)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

ZS Pharma (NASDAQ ZSPH) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for ZS Pharma (NASDAQ:ZSPH)

ZS Pharma (NASDAQ ZSPH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2015Todd A. CreechCFOSell70,000$49.84$3,488,800.00View SEC Filing  
6/8/2015Alta Partners Viii, L.P.Major ShareholderSell175,427$57.86$10,150,206.22View SEC Filing  
6/4/2015Alta Partners Viii, L.P.Major ShareholderSell111,597$57.30$6,394,508.10View SEC Filing  
6/2/2015Alta Partners Viii, L.P.Major ShareholderSell296,423$58.00$17,192,534.00View SEC Filing  
6/23/2014A/S NovoInsiderBuy275,000$18.00$4,950,000.00View SEC Filing  
6/23/2014Guy P NohraDirectorBuy200,000$18.00$3,600,000.00View SEC Filing  
6/23/2014Park Bioventures Lp DevonMajor ShareholderBuy160,000$18.00$2,880,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


ZS Pharma (NASDAQ ZSPH) News Headlines


SEC Filings

ZS Pharma (NASDAQ:ZSPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


ZS Pharma (NASDAQ:ZSPH) Income Statement, Balance Sheet and Cash Flow Statement


ZS Pharma (NASDAQ ZSPH) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.